Healthcare & Life Sciences
Acrivon Therapeutics
United Statesacrivontherapeutics.net
Acrivon Therapeutics is a series c plus startup. 1 investor tracked. Status: possibledead.
unknownseries-c-plus
series-c-plus
Stage
2
Investors
About Acrivon Therapeutics
Acrivon Therapeutics is a company headquartered in the United States. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
Acrivon Therapeutics is a biopharmaceutical company leveraging its proprietary proteomics-based patient responder ID platform, Acrivon Predictive Precision (APPTM), to develop highly-selective oncology drugs.
Explore Acrivon Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.